Howe & Rusling Inc Seres Therapeutics, Inc. Transaction History

Howe & Rusling Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 15, 2020	SELL	$3.04 - $6.2 $310 - $632	-102 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$2.64 - $3.82 $15 - $22	-6 Reduced 5.56%	102 $0
Q2 2019 Aug 12, 2019	SELL	$2.28 - $7.35 $9 - $29	-4 Reduced 3.57%	108 $0
Q1 2019 Apr 29, 2019	SELL	$4.83 - $7.21 $19 - $28	-4 Reduced 3.45%	112 $1,000
Q4 2018 Feb 04, 2019	BUY	$4.52 - $8.88 $131 - $257	29 Added 33.33%	116 $1,000
Q1 2018 May 14, 2018	SELL	$7.34 - $11.16 $132 - $200	-18 Reduced 17.14%	87 $1,000
Q3 2017 Oct 18, 2017	BUY	$12.81 - $16.85 $1,345 - $1,769	105	105 $2,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.